Bacteremia in Febrile, Non-neutropenic, and Well-appearing Children With Cancer

J Pediatr Hematol Oncol. 2022 Jan 1;44(1):e194-e198. doi: 10.1097/MPH.0000000000002201.

Abstract

Fever in a neutropenic pediatric oncology patient requires prompt assessment due to the risk of infectious complications. The appropriate management of fever in non-neutropenic patients, however, is not well-established. We describe the rate of bacteremia in a cohort of non-neutropenic pediatric oncology patients with fever at a large institution. Patients were included if they presented to the emergency department or outpatient clinic between 2009 and 2014 with fever, had a central venous catheter (CVC), and were not neutropenic. Three hundred eighty-six episodes of fever occurring in 159 patients were included in the data analysis. Fifty-nine percent of patients were male, 41% had a diagnosis of acute lymphoblastic leukemia, and 90% had a port-a-cath as CVC. The rate of bacteremia was 3.4%; presence of a port-a-cath was protective against bacteremia whereas a white blood cell count >20,000/mm3 was associated with a higher likelihood of bacteremia. Gram-positive microorganisms were most commonly isolated (64.3%) and frequently resistant to cephalosporins. In summary, in our study, the rate of bacteremia was low among non-neutropenic, well-appearing pediatric cancer patients with a CVC and was not associated with any serious medical complications. Prospective research is needed to determine the most appropriate management of these patients.

Publication types

  • Observational Study

MeSH terms

  • Anti-Bacterial Agents / administration & dosage*
  • Bacteremia* / blood
  • Bacteremia* / drug therapy
  • Bacteremia* / epidemiology
  • Bacteremia* / microbiology
  • Catheterization, Central Venous
  • Central Venous Catheters
  • Child
  • Child, Preschool
  • Female
  • Fever* / blood
  • Fever* / drug therapy
  • Fever* / epidemiology
  • Fever* / metabolism
  • Humans
  • Male
  • Neoplasms* / blood
  • Neoplasms* / drug therapy
  • Neoplasms* / epidemiology
  • Neoplasms* / microbiology
  • Retrospective Studies

Substances

  • Anti-Bacterial Agents